Welcome to our dedicated page for Core Scientific news (Ticker: CORZ), a resource for investors and traders seeking the latest updates and insights on Core Scientific stock.
Core Scientific, Inc. (NASDAQ: CORZ) is active in data processing, hosting and related services, with a focus on digital infrastructure for high-density colocation and digital asset mining. News about Core Scientific often centers on its strategic shift from a primarily bitcoin mining profile toward a broader role in high-performance computing and artificial intelligence-related workloads.
Recent company announcements highlight its plan to convert most existing facilities to support AI-related workloads and next generation colocation services, while repurposing remaining digital asset mining sites for high-density colocation computing. Investors following CORZ news can track updates on this transition, including changes in revenue mix among digital asset self-mining, hosted mining and high-density colocation segments.
Another key news theme is corporate and capital markets activity. Core Scientific entered into an Agreement and Plan of Merger with CoreWeave, Inc. in July 2025, which would have resulted in an all-stock acquisition. Subsequent press releases and Form 8-K filings reported the scheduling of a special meeting of stockholders, proxy-related communications and litigation challenging merger-related disclosures. On October 30, 2025, the company announced that stockholders did not approve the merger proposal and that the Merger Agreement was terminated, with Core Scientific remaining a standalone, publicly traded company on Nasdaq.
Coverage of CORZ also includes quarterly financial results, such as revenue contributions from digital asset self-mining, hosted mining and high-density colocation, as well as investor calls and presentations. In addition, third-party commentary from shareholders and potential acquirers provides perspectives on Core Scientific’s assets, power access and role in the AI infrastructure build-out. For ongoing context on these developments, the CORZ news page aggregates company releases, investor communications and related market commentary.
Core Scientific (Nasdaq: CORZ) announced on October 30, 2025 that at a special meeting of stockholders the company did not receive the requisite votes to approve its previously announced merger agreement with CoreWeave (Nasdaq: CRWV).
The company said the final voting results will be reported in a Form 8-K to be filed with the U.S. Securities and Exchange Commission.
Two Seas Capital (NASDAQ: CORZ) issued a letter on Oct 28, 2025 urging Core Scientific shareholders to vote AGAINST the proposed sale to CoreWeave (announced July 7, 2025). Two Seas says the deal values Core Scientific at $16.40 per share and argues that Core Scientific has materially higher standalone upside—claiming the stock would trade at more than twice the deal value if aligned with AI-infrastructure peers.
The letter highlights Core Scientific's access to low-cost power, operational expertise, and a 700-megawatt pipeline, and warns that approving the transaction would transfer value to CoreWeave. Shareholders face a vote at a special meeting on Oct 30, 2025.
Core Scientific (NASDAQ: CORZ) reported fiscal Q3 2025 results with total revenue $81.1M versus $95.4M a year earlier and gross profit $3.9M vs. a prior-year gross loss. Digital asset self-mining revenue fell to $57.4M, driven by a 55% decline in bitcoin mined despite an 88% higher average bitcoin price. High-density colocation revenue rose to $15.0M from $10.3M. Net loss narrowed to $146.7M from $455.3M, partly due to smaller non-cash fair-value adjustments. Adjusted EBITDA was a $2.4M loss. Q3 capital expenditures totaled $244.5M, of which $196.4M was funded by CoreWeave. Liquidity stood at $694.8M (cash $453.4M; bitcoin $241.4M). CoreWeave proposed an all-stock merger at an exchange ratio of 0.1235, with a stockholder vote scheduled for October 30, 2025.
CoreWeave (NASDAQ: CRWV) commented on proxy-advisor recommendations opposing its proposed all-stock acquisition of Core Scientific (NASDAQ: CORZ), urging CORZ stockholders to vote FOR on the WHITE proxy card on October 30, 2025. CoreWeave says the agreed transaction represents fair value, notes there will be no increase to the offer price, and asserts no other buyer has emerged since its June 2024 approach. Under the definitive agreement signed July 7, 2025, Core Scientific shareholders will receive 0.1235 newly issued CoreWeave Class A shares per CORZ share. The boards of both companies unanimously approved the merger, which is expected to close in Q4 2025, subject to customary closing conditions including regulatory and stockholder approval.
Two Seas Capital urged Core Scientific shareholders (NASDAQ: CORZ) to vote AGAINST the proposed sale to CoreWeave (NASDAQ: CRWV) announced July 7, 2025. Two Seas argues the deal substantially undervalues Core Scientific, citing market moves since the announcement: several peer data-center/HPC stocks have roughly tripled, while CoreWeave's stock has fallen ~15%, leaving the implied deal value near $17.50 per share.
Two Seas highlights Core Scientific trading ~12% above the deal value as of Oct 16, 2025, and that the stock traded above the implied value for 44 straight days, urging shareholders to reject the transaction on the GOLD proxy card.
Two Seas Capital (NASDAQ:CORZ) urged Core Scientific shareholders to vote AGAINST the proposed sale to CoreWeave (NASDAQ:CRWV) on Oct 17, 2025, arguing the transaction substantially undervalues Core Scientific.
Two Seas cites sector moves since the July 7 announcement: peer stocks have roughly tripled, a recent $40 billion data‑center portfolio deal, CoreWeave's stock is down ~15% since the deal announcement, and the implied deal consideration (~$17.50 per share) compares unfavorably to an estimated ~$45 per share if Core Scientific tracked its weakest peer. Two Seas notes Core Scientific traded above the deal value for 44 consecutive days and about 12% higher than the deal value at yesterday's close.
Summary not available.
Two Seas Capital, the largest active shareholder of Core Scientific (NASDAQ: CORZ), published an investor presentation urging shareholders to vote AGAINST Core Scientific's proposed sale to CoreWeave (NASDAQ: CRWV).
Two Seas argues the deal announced July 7, 2025 is the product of a flawed process, has a deficient structure, and features an inadequate exchange ratio that substantially undervalues Core Scientific. The presentation cites peers that "more than doubled" in value in the three months after the deal announcement and highlights the company’s special meeting on October 30, 2025 where shareholders will vote using the GOLD proxy card.
Two Seas Capital LP, the largest active shareholder of Core Scientific (NASDAQ: CORZ), has filed a definitive proxy statement opposing the company's proposed sale to CoreWeave (NASDAQ: CRWV). The investment firm is urging shareholders to vote AGAINST the transaction announced on July 7, 2025.
Two Seas criticizes the deal on multiple fronts: the valuation is deemed inadequate, the structure is considered deficient, and the process was flawed as no other parties were contacted. The market's reaction was notably negative, with CORZ stock plunging 18% on the announcement day. Two Seas argues that CoreWeave's stock, which had appreciated over 300% in just months before the deal, is being used as currency in a transaction that undervalues Core Scientific's potential in the AI data center market.
The firm particularly criticizes the immediate executive benefits, including accelerated vesting and excise tax reimbursement, while shareholders are deprived of long-term value in the AI infrastructure sector.
Core Scientific (NASDAQ: CORZ), a digital infrastructure and mining company, reported its Q2 2025 financial results, showing significant revenue declines and continued losses. Total revenue fell to $78.6 million from $141.1 million year-over-year, with digital asset mining revenue dropping to $62.4 million from $110.7 million.
The company reported a net loss of $936.8 million, largely due to non-cash fair value adjustments of $910.0 million. Notably, Core Scientific announced a pending all-stock merger with CoreWeave, where shareholders will receive 0.1235 shares of CoreWeave Class A common stock for each CORZ share.
The company maintains a strong liquidity position of $754.1 million, including $581.3 million in cash and $172.8 million in digital assets.